Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Lack of Association Between Endothelial Nitric Oxide Synthase Polymorphisms and Henoch-Schönlein Purpura

MAHSA M. AMOLI, CARLOS GARCIA-PORRUA, MARIA C. CALVIÑO, WILLIAM E.R. OLLIER, and MIGUEL A. GONZALEZ-GAY

ABSTRACT.

Objective.
To assess the influence of endothelial nitric oxide synthase (eNOS) polymorphisms in the susceptibility and clinical expression of patients with cutaneous vasculitis fulfilling classification criteria for Henoch-Schönlein purpura (HSP).

Methods. Fifty patients from Northwest Spain with primary cutaneous vasculitis classified as HSP were studied. Patients and ethnically matched controls (n = 117) were genotyped by polymerase chain reaction techniques for a variable-number tandem-repeat polymorphism in intron 4, a T/C polymorphism at position –786 in the promoter region, and a polymorphism in exon 7 (298Glu/Asp or 5557G/T) of the eNOS gene.

Results. No differences in allele or genotype frequencies for any of the individual eNOS polymorphisms were observed between patients fulfilling HSP classification criteria and controls, or when patients were stratified for the presence of nephritis or joint or gastrointestinal manifestations. In the HSP group no linkage disequilibrium between these polymorphisms was found. No significant difference in haplotype frequencies was observed between patients and controls.

Conclusion. Our results do not support a role for these polymorphisms in the susceptibility to HSP. (J Rheumatol 2004;31:299-301)

Key Indexing Terms:

HENOCH-SCHÖNLEIN PURPURA
eNOS POLYMORPHISM
DISEASE SUSCEPTIBILITY
HAPLOTYPE ASSOCIATIONS


From the Centre for Integrated Genomic Medical Research, School of Epidemiology and Health Sciences, the University of Manchester, Manchester, United Kingdom; and the Divisions of Rheumatology and Pediatrics, Hospital Xeral-Calde, Lugo, Spain.

M.M. Amoli, MD, PhD; W.E.R. Ollier, PhD, FRCPath, Centre for Integrated Genomic Medical Research, University of Manchester; M.A. Gonzalez-Gay, MD, PhD; C. Garcia-Porrua, MD, PhD, Rheumatology Division; M.C. Calviño, MD, Pediatrics Division, Hospital Xeral-Calde.

Address reprint requests to Dr. M.A. Gonzalez-Gay, Rheumatology Division, Hospital Xeral-Calde, Dr. Ochoa s/n, 27004 Lugo, Spain. E-mail: miguelaggay@hotmail.com

Submitted March 11, 2003; revision accepted July 4, 2003.




Return to February 2004 Table of Contents



© 2004. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.